Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells

INTRODUCTION: Patients with persistently active autoimmune diseases are considered to be candidates for autologous SCT. We performed a phase 1/2 study in a limited number of patients who were refractory to conventional immunosuppressive treatment. Following a period of uncontrolled disease activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, Oliver, Thiel, Andreas, Massenkeil, Gero, Hiepe, Falk, Häupl, Thomas, Radtke, Hartmut, Burmester, Gerd R, Gromnica-Ihle, Erika, Radbruch, Andreas, Arnold, Renate
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2000
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17815/
https://www.ncbi.nlm.nih.gov/pubmed/11056673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC17815/
https://www.ncbi.nlm.nih.gov/pubmed/11056673

Ejemplares similares